Page 2 - Carnot
P. 2

Smart chemistry


          for a better



          future





          I2C, a Carnot Institute

             As a key research & innovation player for industry                   Target markets
           in Chemistry, Carnot I2C develops tailored
           bilateral collaborations with companies (from start                • Cosmetics
           ups, SMEs to large groups), and builds long-term                   • Chemistry for health
           relationships.                                                     •  Chemistry and Sustainable
             I2C supports its industrial partners with                           Industry
           differentiating application solutions and
           fundamental chemical & life sciences by
           integrating the criteria of sustainability that ensure
           competitiveness in their markets.

             A professional research partnership.
             A commitment to Quality (ISO 9001 certified).







          A multidisciplinary

          technological research network                       Galénique (vectorisation, cristallisation sélective et
                                                               polymorphisme)
             8 French public research centers in chemistry
           (CERMN, COBRA, Glyco-MEV, ISTCT/LDM-TEP,
           LCMT, PBS, SMS, URCOM) that are sustaining
           close ties for more than 25 years.

             Around 500 researchers that deliver solid
           expertises ranging from organic and
           pharmaceutical synthesis, chemical analysis and
           formulation with the aim of creating value through
           innovation.

             Over the years, I2C invested heavily in its facilities
           to secure its place as a major research institute.
           It is now 7 accessible technological platforms
           (synthesis & technology, cosmetomic, drug
           design, cellular & biomedical imaging, proteomic,
           medicinal chemistry, organic materials) and to
           Infranalytics

                                                               Le donécopride : une stratégie multi-cibles en phase
                                                               d’essais précliniques dans la maladie d’Alzheimer
   1   2   3   4